You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunobridging

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Pandemic, COVID-19 Vaccines Trial in Surabaya (Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg,

Recruiting
  • COVID-19 Pandemic
  • COVID-19 Vaccines
  • Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
  • CoronaVac Biofarma COVID-1 9 Vaccine 3 µg
  • Surabaya, East Java, Indonesia
    Dr. Soetomo General Hospital
Jun 21, 2023

COVID-19 Trial in Yancheng (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml, Recombinant Novel

Active, not recruiting
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml
  • Yancheng, Jiangsu, China
    Funing Center for Disease Control and Prevention
Oct 28, 2022

Papillomavirus Infections Trial in Quzhou, Shaoxing (V503)

Active, not recruiting
  • Papillomavirus Infections
  • V503
  • Quzhou, Zhejiang, China
  • +1 more
Aug 17, 2022

COVID-19 Pandemic, COVID-19 Vaccines Trial in Jember, Malang, Surabaya (Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell

Recruiting
  • COVID-19 Pandemic
  • COVID-19 Vaccines
  • Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
  • CoronaVac Biofarma COVID-19 Vaccine
  • Jember, East Java, Indonesia
  • +4 more
Aug 18, 2022

HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Hangzhou (9-valent HPV vaccine)

Recruiting
  • HPV Infections
  • +14 more
  • 9-valent HPV vaccine
  • Hangzhou, China
    Huakun Lv
Feb 23, 2022

Covid19 Trial in Xinxiang (3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated, 3-doses schedule 2 of COVID-19

Recruiting
  • Covid19
  • 3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated
  • +3 more
  • Xinxiang, Henan, China
    Yanjin County Center for Disease Control and Prevention
Jun 15, 2022

Human Papilloma Virus Trial in Mwanza (bivalent HPV vaccine, nonavalent HPV vaccine)

Active, not recruiting
  • Human Papilloma Virus
  • bivalent HPV vaccine
  • nonavalent HPV vaccine
  • Mwanza, Tanzania
    Mwanza Intervention Trials Unit (MITU)
Jan 19, 2021

SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (Biological/Vaccine: BNT162b2 10mcg, BNT162b2 20mcg, BNT162b2 30mcg)

Active, not recruiting
  • SARS-CoV-2 Infection, COVID-19
  • Biological/Vaccine: BNT162b2 10mcg
  • +4 more
  • Birmingham, Alabama
  • +134 more
Jan 23, 2023

Human Papillomavirus Vaccine Trial in Banjul (9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses, 9-valent human

Active, not recruiting
  • Human Papillomavirus Vaccine
  • 9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses
  • +2 more
  • Banjul, Outside U.S. And Canada, Gambia
    Ed Clarke
Mar 15, 2022

SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +4 more
  • Athens, Alabama
  • +158 more
Jul 18, 2022